Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Update

Covalon Technologies Ltd. (OTCMKTS:CVALF - Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 1,300 shares, a decline of 50.0% from the November 30th total of 2,600 shares. Based on an average daily volume of 29,100 shares, the short-interest ratio is currently 0.0 days.

Covalon Technologies Stock Up 3.8 %

OTCMKTS CVALF traded up $0.08 on Friday, hitting $2.28. The stock had a trading volume of 15,112 shares, compared to its average volume of 16,108. The company's 50-day moving average is $2.50 and its two-hundred day moving average is $2.14. Covalon Technologies has a one year low of $0.74 and a one year high of $3.08. The stock has a market cap of $62.47 million, a price-to-earnings ratio of -75.97 and a beta of -0.31.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.